newsfilter
← Latest News
GlobeNewswire·

Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update

Completed initial public offering, raising $174.4 million in gross proceeds, including full exercise of the underwriters' option to purchase additional shares and a concurrent private placement, to fund clinical